Companies / Royalty Pharma plc

Royalty Pharma plc

Nasdaq: RPRXCIK 1802768NEW YORK, NY

Financials · FY2025

Revenue$2.38B
Net income$1.32B
Total debt$8.96B
Cash$811.99M
Diluted EPS$1.78
Shares outstanding575.0M

Ownership

575.0M shares outstanding · as of Jul 31, 2026
100.0%Public float
Ownership
77.4%Class A
Share classes
Class A77.44%
Class B22.56%
Public float100.00%575,001,204

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 9

View all →
Insider% of sharesShares
Bassler Bonnie LDirector
——
Coyne Terrance P.EVP & CFO
——
Hite ChristopherEVP & Vice Chairman
——
Hodgson David CDirector
——
Legorreta Pablo G.CEOCEO, Chairman of the Board · Director
——
Love Ted WDirector
——
McGivern Arthur RichardEVP, Investments & GC
——
Urist MarshallEVP, Research & Investments
——
Weatherman Elizabeth HDirector
——

Institutional holders 0

HolderValue% of shares
No institutional holders on file.

Activity

—View all →
InsidersInstitutions
Who's accumulating and trimming this stock (13F).
No activity matches these filters.

5%+ ownership events

Schedule 13D / 13G
FilerStance% of classSharesDate
Capital International InvestorsPassive13G/A———